Dr. Rachel S. Goldstein Facebook ad: “Feel Like Yourself Again”

About this ad

Meta Ad Library ID

26060796033616052

Platforms

Facebook, Instagram, Messenger and Threads

Relaunches

0

Niche

Supplements & Wellness

How we count

Ad text

I'm an endocrinologist, and I owe my GLP-1 patients an apology. For five years I've been telling them to "eat protein and stay active" after they stop their medication. Last month, a patient proved me wrong. Not because she gave up on my advice. Because something had changed that I have never seen in a post-GLP-1 patient. I've been treating obesity and metabolic disease for 22 years. I've prescribed GLP-1 medication to over 800 patients. I've watched the scale drop 40, 60, 80 pounds. I've celebrated these outcomes with patients who cried in my office because they finally felt like themselves. And then I've watched them stop the medication. Insurance denials. $2,000 a month they couldn't afford. Side effects they couldn't tolerate. Shortages. Every single time, the same result. The weight comes back. 60% within a year according to the Lancet meta-analysis — 48 studies analyzed, the most comprehensive data on post-GLP-1 weight outcomes ever collected. And every single time, I said the same thing. "Keep eating well. Stay active. You've built good habits." Last month, that changed. Because of Diane. Diane didn't grow up overweight. She never dieted. She was 128 pounds from the time she was 25 until the day she turned 48. She ran three mornings a week. She ate well without thinking about it because she'd never had to think about it. That was just who she was. Then perimenopause hit and her body took her for a ride. She didn't change a single thing. She gained 10 pounds the first year. She blamed her dryer for shrinking her clothes. The second year, another 15. By the time she walked into my office at 52, she was 193 pounds. She'd gained 65 pounds while doing everything the same. "I didn't change anything," she told me. "My body did." She'd tried everything by then. Keto. Intermittent fasting. A personal trainer four days a week. 1,200 calories a day. The scale didn't move. Even eating a stupidly low amount of calories did nothing. The rules had changed and nobody told her. Her previous doctor offered an antidepressant and told her to eat less and move more. She was already eating less than her teenage daughter and running three times a week. I prescribed her a GLP-1 medication. Within five months, she'd lost 52 pounds. "Nothing worked. Keto, macros, four days a week with weights — I kept gaining. This was the first thing that actually did something. It was like my body remembered how to lose weight again." She could eat a normal portion and feel done. She could cook dinner without standing at the stove eating half of it before anyone sat down. It was like someone turned off a noise she didn't know was playing — this constant hum of hunger that had been running in the background for four years. Gone. She came in at five months and she was 141 pounds. She stood on the scale and said, "I don't see my mother in the mirror anymore." Six months before, she'd looked in the mirror and seen her mother. Her mother who'd gained weight in her fifties and never lost it. Who'd stopped buying clothes that fit and started buying clothes that hid. Diane felt like her mother had consumed her. She didn't have words for the feelings. At 141, she could see herself again. That was May. In October, her insurance switched plans and the medication was no longer covered. No warning. No taper plan. Just a letter and a $2,000 monthly bill she couldn't pay. I told her what I told every patient. Keep eating the way you've been eating. Stay active. You'll be fine. She wasn't fine. She tried. She kept her meals the same. Same portions. Same runs. She did everything I told her to do. The hunger came back within two weeks. Not the perimenopause hunger she'd lived with for four years. Something she'd never experienced in 52 years. Something that didn't feel like hers. She told me later: "I have never been a person who struggles with food. That was never me. And suddenly I'm lying awake at midnight with my stomach screaming at me like I haven't eaten in days. I'd already had a full dinner. And my brain wouldn't stop. I was standing in the kitchen at 1am eating out of the pot because I physically could not stop myself. It didn't feel human. It felt like my body was punishing me for ever thinking I could be thin again." She didn't binge. She didn't fall off. She maintained the same diet. And in four months she gained every pound back. Plus eight. She described it like this: "Menopause did me dirty the first time. Then the drug fixed it. Then the drug was taken away and the fat came rushing back going 'Surprise! You thought you could get rid of me? Gotcha.' I'm heavier now than before I started." When she came back into my office in February, she was wearing a coat zipped to her chin. She stared at the floor. "I was 128 pounds for 23 years," she said. "I ran. I ate well. I did nothing wrong. And now I'm 201 pounds and my legs shake when I walk up stairs. I feel like my old self died last year and she's gone forever." She looked up at me. "Don't tell me to eat less and move more. That answer is not good enough anymore." She left. And I sat in my office for a long time. Because Diane wasn't wrong. She was asking why her body had betrayed her — first from menopause, then from stopping the medication. And I didn't have an answer. After she left, I pulled her body composition scans. I'd been so focused on the total weight number that I'd never looked at what was underneath. When Diane started her GLP-1 at 193 pounds, she had 72 pounds of lean mass. Muscle, bone, organ tissue. Five months later at 141 pounds, she had 54 pounds of lean mass. She hadn't just lost 52 pounds. Eighteen of those pounds were muscle. A quarter of her lean tissue. Gone. Menopause had already been eroding her muscle before the drug accelerated it. She was being eaten from both sides — estrogen decline from one, caloric deficit from the other — and nobody said a word. I'd celebrated her weight loss. I'd never once mentioned the muscle. This wasn't a Diane problem. The Lancet published a paper in November 2024 showing that up to 39 percent of total weight lost on GLP-1 medications is not fat. It's lean mass. Muscle and bone. The authors called it a serious clinical concern. I'd read that paper when it came out. I'd nodded at my desk. I hadn't changed a single thing about how I treated my patients. Now I was staring at Diane's scans and the math was obvious. Diane lost 18 pounds of muscle. Each pound of muscle burns about 13 calories per day at rest. That's 234 fewer calories her body burned every single day just existing. Because the engine that was supposed to burn the fuel had been carved down while I was congratulating her on the weight loss. So when the appetite came back — and it comes back with a vengeance, the rebound hunger overshoots baseline — Diane's body was running a smaller engine against louder hunger. The math was never going to work. And here's the part that made me sit in my office after she left. When the weight came back, it didn't come back the way it left. The fat returned. The muscle did not. Diane regained 60 pounds, and nearly all of it was fat. Her body now had more fat and less muscle than before she'd ever started the medication. She was heavier. Weaker. Her metabolism was permanently slower. Her body fat percentage was higher than when she began. And she thought her body was just broken. That menopause had ruined her and that was that. That's what I owe an apology for. Not for prescribing the medication. It worked. I'd prescribe it again. But for five years I watched patient after patient lose muscle on these drugs, and I never did a single thing about it. I told them to eat protein and exercise while they were too nauseated and exhausted to do either. "Between the medication fatigue and the menopause fatigue, I couldn't get through a workday," Diane told me. "I wasn't going to the gym. I was barely going to work." I was prescribing exercise to a woman being drained from two directions at once. After Diane left that day, I stopped asking "how do I help patients keep the weight off" and started asking a different question. Why does the body cannibalize so much muscle during GLP-1 treatment? And is there anything that can stop it? Not "eat more protein." Not "lift weights." Something that works at the molecular level, at the site where muscle tissue is being broken down. Here's what I found. During caloric restriction — which is exactly what GLP-1 drugs create through appetite suppression — the body upregulates a protein called myostatin. Myostatin is a brake on muscle growth. It signals your muscle tissue to break down. When food is scarce, muscle is expensive to maintain. So the body destroys its own engine to conserve fuel. Except Diane wasn't surviving a famine. She was on a prescription medication. And her body was responding to the caloric deficit by eating its own metabolic engine. That's why the weight comes back. That's why 60% is regained within a year. The engine that was supposed to sustain the lower weight was consumed on the way down. You're not failing the diet. The drug ate your metabolism. There's a difference. I needed something that blocks myostatin. Something that tells the body to keep the muscle even during caloric restriction. The pharmaceutical industry already knows this is the answer. Regeneron, a $90 billion company, ran a Phase 2 clinical trial testing anti-myostatin antibodies combined with GLP-1 medication. Patients preserved up to 81 percent more muscle. Fat loss increased up to 27 percent. More engine means more burn. Their solution is an injectable antibody. Years from approval. Will cost thousands. But the myostatin pathway isn't locked behind a patent. There's a compound called epicatechin. A flavanol found in cocoa. It accesses the same mechanism through a different door. I almost didn't look into it. "Cocoa flavanols" sounds like something from a wellness blog. Then I read the data. Researchers at UC San Diego gave subjects epicatechin at 25 milligrams twice a day. In seven days — one week — hand grip strength increased and the follistatin-to-myostatin ratio shifted measurably toward muscle preservation. Follistatin blocks myostatin. When follistatin goes up and myostatin goes down, muscle is protected. One week. Measurable shift. A 2019 randomized controlled trial tested epicatechin in 62 older adults actively losing muscle. Epicatechin plus resistance training outperformed training alone across every measure — leg press, chest press, follistatin levels, and muscle mass. A 2024 systematic review in Nutrients confirmed the pattern: consistent inhibition of myostatin and activation of myogenic factors that build new tissue. This wasn't wellness. This was clinical data targeting the exact pathway Regeneron was spending hundreds of millions to hit with injectable antibodies. Oral, daily, available without a prescription. I called Diane. "I need to tell you something. I found what's actually happening to your body and why the weight came back. And I want you to try something." She was quiet. She'd been quiet with me since February. I'd lost some of her trust. "It's not a drug. It's not going to suppress your appetite. Nothing over the counter will do what a GLP-1 did and I'm not going to tell you otherwise." "Then what does it do?" "It protects your muscle. The protein breaking down your muscle tissue is called myostatin. When you were on the medication eating fewer calories, your body ramped up myostatin and destroyed muscle to conserve energy. You lost 18 pounds of muscle in five months. And menopause was already stripping muscle before the drug started. You were losing it from two directions and nobody protected it from either one. That's why the weight came back. This compound blocks myostatin. The same pathway a $90 billion pharmaceutical company is targeting right now in clinical trials." Silence. "I lost 18 pounds of muscle?" "Yes. I should have been monitoring it. I should have done something about it while you were on the drug. I didn't." More silence. "So the weight came back because my body ate its own engine?" "The weight came back because the tissue that runs your metabolism was consumed by the caloric deficit the drug created — on top of what menopause was already taking. Rebuild the muscle, and the math changes. That's what I'm asking you to try." She agreed. Mostly because I'd finally given her an answer that wasn't "eat less and move more." A specific protein, doing a specific thing, that could be specifically blocked. I recommended a specific cocoa flavanol supplement called Nuvie. This matters, and I want to explain why. Most cocoa products are processed using high heat and alkalization — standard chocolate manufacturing. That destroys 90 percent of the flavanols, including the epicatechin that drives the myostatin inhibition. What's left doesn't cross the therapeutic threshold. Diane tried a generic cocoa supplement first. Amazon, $15. Two weeks. Nothing. I told her that was expected. The epicatechin concentration has to match what was used in the clinical studies. Nuvie standardizes to that concentration and third-party tests for it. That's why I recommended it specifically. She switched to Nuvie and started taking it daily. Week one. She noticed nothing dramatic. "I don't know. Maybe? I feel a tiny bit less tired but honestly it could be in my head." I told her that was consistent with the research timeline. The myostatin shift begins within days at the cellular level but subjective changes take longer to accumulate. Week two. She called me. "Okay, something's happening. I slept seven hours last night and I didn't wake up wanting to die. I've been doing 10, 11 hours and waking up like I'd been hit by a truck — you know how it is with menopause on top of everything else. Last night I slept seven and I just... got up. Like a normal person. I haven't done that in two years." That's consistent with what epicatechin does beyond myostatin inhibition. It improves mitochondrial function — the energy production inside every cell. When the mitochondria work more efficiently, the cellular fatigue lifts. Not because of stimulation. Because the power generators are actually producing what they should. Week three. "I went for a run. I know. I haven't run since June. My legs have felt like concrete for months — you know that heavy dead feeling? Gone. I only did 20 minutes but I could have kept going. I came home and I wasn't wrecked. I wasn't on the couch for two hours after. I just... did stuff. Like I used to." Better muscle function. Better energy production in the muscle cells. Her muscles were beginning to function like muscles again instead of depleted tissue running on fumes. Month one. I ran her body composition. Her lean mass had stabilized. Since stopping the medication, she'd been losing about a pound of muscle per month on top of the fat regain. That erosion had stopped. The muscle was holding. Month two. The lean mass number ticked up. She'd lost four pounds of fat and gained half a pound of muscle. The scale showed a 3.5 pound drop. But underneath, the shift was bigger — less fat, more muscle. The engine was rebuilding. And her resting metabolic rate had jumped by 140 calories per day. Not from exercise. Not from eating differently. Her body was burning 140 more calories a day doing absolutely nothing — sitting on the couch, sleeping, watching TV. The engine was bigger and running hotter. For a menopausal woman whose metabolism had been stripped from two directions, 140 calories a day is not a rounding error. That's a pound of fat every 25 days. From doing nothing different. And she told me something I wasn't expecting. "The hunger's different. It's not gone — nothing's going to make it gone like the medication did. But I'm not standing at the fridge at midnight anymore. I made dinner last night and I actually sat down and ate it and that was it. I wasn't picking at stuff while I was cooking. I wasn't already thinking about what's next. I haven't been able to do that since I stopped." When the body is burning 140 more calories a day at rest, it's not in metabolic emergency anymore. The hunger signal doesn't need to scream as loud because the body isn't running a deficit just to exist. Diane's midnight cravings weren't a discipline problem. They were a depleted body demanding fuel through a brain already primed by menopause to overeat. Rebuild the engine, and the signal quiets down. Month three. Down 11 pounds. But 13 of those pounds were fat. Her muscle mass had increased by two pounds. For the first time since perimenopause started, her body was doing what it used to — burning fat, holding muscle. And with the combined effect of more muscle, better mitochondrial function, and a body no longer in caloric emergency, she was burning around 400 more calories per day than she had been three months earlier. 400 calories. That's an hour on a treadmill. Every day. Without the treadmill. Month five. Down 20 pounds. Muscle mass continuing to increase. She came in wearing running clothes. Not a coat zipped to her chin. "I need to tell you something," she said. "What?" "When I was on the medication, I was thinner. But I was a mess. I was nauseous all the time. I was sleeping half the day. My joints were killing me — and I couldn't tell what was the drug and what was menopause. I was losing weight but I felt like crap. Honestly? I felt like my body was just shutting down. Getting smaller but not getting better." She paused. "Honestly? I didn't expect anything. After everything I've tried since perimenopause, I figured this would be another thing that didn't work. But I'm running again. Not far. Not fast. But running. And I'm sleeping through the night. And the belly fat that sat there through keto, IF, 1200 calories — it's actually moving. I feel like my body is working with me instead of against me for the first time in four years." I've since recommended Nuvie to every GLP-1 patient I see. For patients currently on the drug — to protect the muscle while the weight comes off. For patients who've already stopped and are watching the regain happen — to start rebuilding the engine. For patients who can't afford the drug anymore and need something that addresses the actual metabolic damage. Not the appetite. The muscle. It won't replace a GLP-1. Nothing will. But the reason the weight comes back isn't appetite. It's that the tissue that was supposed to sustain your new weight got eaten on the way down. Rebuild that tissue, and the math changes. Nuvie has a 30-day money-back guarantee. They produce in limited quantities to maintain the flavanol integrity. When they sell out, it's usually weeks before the next batch. If you're reading this because menopause changed your body and nothing you've done has changed it back. If you counted every macro and worked out four days a week and the scale didn't move. If you tried a GLP-1 and it gave you your pre-menopause body back — and then your insurance took it away. And now the hunger is back and it doesn't feel like yours. If you look in the mirror and you see your mother. If you feel like your old self died and she's gone forever. You didn't do anything wrong. Your hormones changed the rules. Then the drug ate your metabolism. And nobody told you either one was happening. Rebuilding that muscle is the one thing that changes the math. And the pathway to do it is the same one a $90 billion pharmaceutical company is betting their pipeline on. Diane was 128 pounds for 23 years. She didn't fail. Menopause and the drug hit her from both sides and nobody protected her from either one. It wasn't her. It was never her. It was the muscle. 👉

Where the ad sends people

trynuvie.com

Feel Like Yourself Again

"This actually worked, thank you!" - Sarah M.